• Revenue $19.8M, +26% vs Prior Corresponding Period
• Gross Margin of 75%, up from 72% in PCP
• EBITDA loss $0.4M, a substantial improvement from $3.9M loss in PCP

CleanSpace Holdings Limited (ASX: CSX), an Australian company that designs, manufactures, and sells premium respiratory protection solutions for industrial and healthcare markets, has released its audited financial results for Financial Year 2025 (FY25). The key highlights include: Revenue of $19.8M, up 26% from the prior corresponding period (PCP), with H2FY25 also up 26%; Gross Margin of 75%, up from 72% in the PCP, due to efficiencies and cost savings in production and operations; EBITDA loss of $0.4M, a substantial improvement from a $3.9M loss in the PCP. Excluding $0.7M of one-off costs in FY25, the Company was EBITDA and NPAT positive, with the Company being EBITDA positive in H2FY25; Positive Cash Flow of $2.2M in H2FY25, with Cash at bank of $10.5M up $0.7M from the PCP as at 30 June 2025; Consumables sales in FY25 were $9.3M (+27% vs PCP) and represented 47% of total sales, an increase from 46% in FY24; Growth and operating profit were achieved in all Regions, with the USA a standout, with revenue +45% vs PCP. The Company's balance sheet remains strong, and operating expenses (excluding depreciation and share-based payments) were tightly controlled at $15M, in line with the PCP.

For FY26, the Company expects: Continued top line growth of >20% driving improved operating leverage; Gross margin in the mid-70% range; Positive EBITDA and Cash Flow; Continuing cost control discipline; Re-investing surplus cash for growth.

The Board remains confident that the Company is on a strong and dynamic growth trajectory, positioning itself as an innovator and aspiring leader in the industrial PAPR sector. Building on recent momentum and market successes, and with targeted investments in sales, marketing and R&D, the Company is well-positioned to accelerate sustainable growth in FY26 and beyond.